An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)
NCT01276405 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 123
Last updated 2016-11-02
Summary
This observational study will evaluate Xeloda (capecitabine) monotherapy on the effect of disease-free survival in patients with colon cancer stage III (Duke C) after surgical resection. Data will be collected for 3 years.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- Romania
Study Locations
More Related Trials
-
An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer
NCT01664494 ·Status: COMPLETED
-
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
NCT00048126 ·Status: COMPLETED ·Phase: PHASE2
-
Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy
NCT00189683 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
NCT02567331 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer
NCT00796718 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer
NCT00394992 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
NCT00048139 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)
NCT00997685 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients
NCT00335595 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer
NCT00421824 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
NCT00118755 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.
NCT00353262 ·Status: COMPLETED ·Phase: PHASE1
-
Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma
NCT00312000 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
NCT00202774 ·Status: COMPLETED ·Phase: PHASE3
-
Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
NCT00208546 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer
NCT01339832 ·Status: COMPLETED
-
A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.
NCT01135498 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
NCT00623805 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin
NCT01077739 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT00642603 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
NCT00069095 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.
NCT01159171 ·Status: COMPLETED ·Phase: PHASE2
-
Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
NCT02060669 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer
NCT02119026 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer
NCT00700570 ·Status: COMPLETED ·Phase: PHASE2